These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 11015203)

  • 61. Underediting of glutamate receptor GluR-B mRNA in malignant gliomas.
    Maas S; Patt S; Schrey M; Rich A
    Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14687-92. PubMed ID: 11717408
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Structures of human ADAR2 bound to dsRNA reveal base-flipping mechanism and basis for site selectivity.
    Matthews MM; Thomas JM; Zheng Y; Tran K; Phelps KJ; Scott AI; Havel J; Fisher AJ; Beal PA
    Nat Struct Mol Biol; 2016 May; 23(5):426-33. PubMed ID: 27065196
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Chronic glutamate treatment selectively modulates AMPA RNA editing and ADAR expression and activity in primary cortical neurons.
    Bonini D; Filippini A; La Via L; Fiorentini C; Fumagalli F; Colombi M; Barbon A
    RNA Biol; 2015; 12(1):43-53. PubMed ID: 25625181
    [TBL] [Abstract][Full Text] [Related]  

  • 64. RNA editing by ADAR2 is metabolically regulated in pancreatic islets and beta-cells.
    Gan Z; Zhao L; Yang L; Huang P; Zhao F; Li W; Liu Y
    J Biol Chem; 2006 Nov; 281(44):33386-94. PubMed ID: 16956888
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A Phenotypic Screen for Functional Mutants of Human Adenosine Deaminase Acting on RNA 1.
    Wang Y; Havel J; Beal PA
    ACS Chem Biol; 2015 Nov; 10(11):2512-9. PubMed ID: 26372505
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Phylogenetic comparison of the pre-mRNA adenosine deaminase ADAR2 genes and transcripts: conservation and diversity in editing site sequence and alternative splicing patterns.
    Slavov D; Gardiner K
    Gene; 2002 Oct; 299(1-2):83-94. PubMed ID: 12459255
    [TBL] [Abstract][Full Text] [Related]  

  • 67. ADAR2-mediated editing of RNA substrates in the nucleolus is inhibited by C/D small nucleolar RNAs.
    Vitali P; Basyuk E; Le Meur E; Bertrand E; Muscatelli F; Cavaillé J; Huttenhofer A
    J Cell Biol; 2005 Jun; 169(5):745-53. PubMed ID: 15939761
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dimerization of ADAR2 is mediated by the double-stranded RNA binding domain.
    Poulsen H; Jorgensen R; Heding A; Nielsen FC; Bonven B; Egebjerg J
    RNA; 2006 Jul; 12(7):1350-60. PubMed ID: 16682559
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Editing of messenger RNA precursors and of tRNAs by adenosine to inosine conversion.
    Keller W; Wolf J; Gerber A
    FEBS Lett; 1999 Jun; 452(1-2):71-6. PubMed ID: 10376681
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Requirement of the RNA-editing enzyme ADAR2 for normal physiology in mice.
    Horsch M; Seeburg PH; Adler T; Aguilar-Pimentel JA; Becker L; Calzada-Wack J; Garrett L; Götz A; Hans W; Higuchi M; Hölter SM; Naton B; Prehn C; Puk O; Rácz I; Rathkolb B; Rozman J; Schrewe A; Adamski J; Busch DH; Esposito I; Graw J; Ivandic B; Klingenspor M; Klopstock T; Mempel M; Ollert M; Schulz H; Wolf E; Wurst W; Zimmer A; Gailus-Durner V; Fuchs H; de Angelis MH; Beckers J
    J Biol Chem; 2011 May; 286(21):18614-22. PubMed ID: 21467037
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Down-regulation of the RNA editing enzyme ADAR2 contributes to RGC death in a mouse model of glaucoma.
    Wang AL; Carroll RC; Nawy S
    PLoS One; 2014; 9(3):e91288. PubMed ID: 24608178
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Site-selective versus promiscuous A-to-I editing.
    Wahlstedt H; Ohman M
    Wiley Interdiscip Rev RNA; 2011; 2(6):761-71. PubMed ID: 21976281
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A method to find tissue-specific novel sites of selective adenosine deamination.
    Ohlson J; Ensterö M; Sjöberg BM; Ohman M
    Nucleic Acids Res; 2005 Oct; 33(19):e167. PubMed ID: 16257978
    [TBL] [Abstract][Full Text] [Related]  

  • 74. ADAR2-mediated Q/R editing of GluK2 regulates kainate receptor upscaling in response to suppression of synaptic activity.
    Gurung S; Evans AJ; Wilkinson KA; Henley JM
    J Cell Sci; 2018 Dec; 131(24):. PubMed ID: 30559217
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A novel RNA pentaloop fold involved in targeting ADAR2.
    Stefl R; Allain FH
    RNA; 2005 May; 11(5):592-7. PubMed ID: 15840813
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Selective inhibition of ADAR2-catalyzed editing of the serotonin 2c receptor pre-mRNA by a helix-threading peptide.
    Schirle NT; Goodman RA; Krishnamurthy M; Beal PA
    Org Biomol Chem; 2010 Nov; 8(21):4898-904. PubMed ID: 20820662
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Editing of glutamate receptor B subunit ion channel RNAs by four alternatively spliced DRADA2 double-stranded RNA adenosine deaminases.
    Lai F; Chen CX; Carter KC; Nishikura K
    Mol Cell Biol; 1997 May; 17(5):2413-24. PubMed ID: 9111310
    [TBL] [Abstract][Full Text] [Related]  

  • 78. High-throughput screening for functional adenosine to inosine RNA editing systems.
    Pokharel S; Beal PA
    ACS Chem Biol; 2006 Dec; 1(12):761-5. PubMed ID: 17240974
    [TBL] [Abstract][Full Text] [Related]  

  • 79. ADAR2 induces reproducible changes in sequence and abundance of mature microRNAs in the mouse brain.
    Vesely C; Tauber S; Sedlazeck FJ; Tajaddod M; von Haeseler A; Jantsch MF
    Nucleic Acids Res; 2014 Oct; 42(19):12155-68. PubMed ID: 25260591
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Elevated activity of the large form of ADAR1 in vivo: very efficient RNA editing occurs in the cytoplasm.
    Wong SK; Sato S; Lazinski DW
    RNA; 2003 May; 9(5):586-98. PubMed ID: 12702817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.